The fasting glucose level for instituting combination therapy is in the range of 150 mg dL in plasma or serum depending on the patient. Glimepiride is white to yellowish-white, crystalline, odorless to practically odorless powder formulated into tablets of 1-mg, 2-mg, and 4-mg strengths for oral administration. IAS 28 Amendment Investment in associates and consequential amendments to IAS 32, Financial Instruments: Disclosure and Presentation. AMARYL treatment did result in slight, glimepiride compra but statistically significant, decrease in the pharmacodynamic response to warfarin. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. Important safety information: Glimepiride may cause drowsiness, dizziness, blurred vision, or lightheadedness.